{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:30:02Z","timestamp":1786516202713,"version":"build-2736575974"},"reference-count":20,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. Medical abortion using mifepristone and misoprostol is effective and safe, but evidence is limited in very early gestation before ultrasound confirmation of an intrauterine pregnancy (IUP).\n\nMETHODS. This single-centre prospective cohort study included 100 women between 2023 and 2025 who requested medical abortion up to 6+0 weeks of gestation and had a non-confirmed IUP on ultrasound (empty cavity or sac-like structure without embryonic pole). Participants initiated immediate medical abortion according to the WHO-recommended protocol. The primary outcome was complete abortion without the need for surgical intervention.\n\nRESULTS. Complete abortion was achieved in 95% of the participants without the need for surgical intervention. The ectopic pregnancy rate was 2%, all of which were diagnosed before rupture. 2% required additional medical treatment, and 2% surgical intervention. No serious adverse events occurred.\n\nCONCLUSIONS. Medical abortion before visible IUP is as effective as standard treatment. Very early medical abortion can be implemented safely and effectively with structured follow-up, allowing for earlier treatment without compromising safety.\n\nFUNDING. None.\n\nTRIAL REGISTRATION. The study was approved by the University Hospital of Southern Denmark, Sygehus S\u00f8nderjylland, record no.:24\/44840.<\/jats:p>","DOI":"10.61409\/a11250983","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:52:26Z","timestamp":1778133146000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Very early medical abortion before confirmed intrauterine pregnancy"],"prefix":"10.61409","author":[{"given":"Ervin","family":"Kallfa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Hoedt","family":"Karstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brita Frederiksen","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn Friis","family":"Lauszus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2026,4]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Upadhyay UD, Coplon L, Atrio JM. Society of Family Planning Committee Statement: abortion nomenclature. Contraception. 2023;126:110094. https:\/\/doi.org\/10.1016\/j.contraception.2023.110094","DOI":"10.1016\/j.contraception.2023.110094"},{"key":"ref1","unstructured":"World Health Organization. Abortion care guideline. World Health Organization, 2022. www.who.int\/publications\/i\/item\/9789240039483 (21 Nov 2025)"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bizjak I, Fiala C, Berggren L, et al. Efficacy and safety of very early medical termination of pregnancy: a cohort study. BJOG. 2017;124(13):1993-1999. https:\/\/doi.org\/10.1111\/1471-0528.14904","DOI":"10.1111\/1471-0528.14904"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins - Gynecology, Society of Family Planning. Medication abortion up to 70 days of gestation: ACOG Practice Bulletin, Number 225. Obstet Gynecol. 2020;136(4):e31-e47. https:\/\/doi.org\/10.1097\/AOG.0000000000004082","DOI":"10.1097\/AOG.0000000000004082"},{"key":"ref4","unstructured":"Royal College of Obstetricians and Gynaecologists. Best practice in abortion care (best practice paper). Royal College of Obstetricians and Gynaecologists, 2022. www.rcog.org.uk\/guidance\/browse-all-guidance\/best-practice-papers\/best-practice-in-abortion-care-best-practice-paper\/ (21 Nov 2025)"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Fiala C, Bombas T, Parachini M, et al. Management of very early medical abortion - an international survey among providers. Eur J Obstet Gynecol Reprod Biol. 2020;246:169-176. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.01.022","DOI":"10.1016\/j.ejogrb.2020.01.022"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kortsmit K, Nguyen AT, Mandel MG, et al. Abortion surveillance - United States, 2021. MMWR Surveill Summ. 2023;72(9):1-29. https:\/\/doi.org\/10.15585\/mmwr.ss7209a1","DOI":"10.15585\/mmwr.ss7209a1"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Barnhart K, van Mello NM, Bourne T, et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril. 2011;95(3):857-866. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.09.006","DOI":"10.1016\/j.fertnstert.2010.09.006"},{"key":"ref8","unstructured":"Axelsson PB, L\u00f8kkegaard ECL, Helm P. A ruptured ectopic pregnancy during early termination of pregnancy before ultrasound confirmation. Ugeskr L\u00e6ger. 2020;182:V11190651"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Flynn AN, Schreiber CA, Roe A, et al. Prioritizing desiredness in pregnancy of unknown location: an algorithm for patient-centered care. Obstet Gynecol. 2020;136(5):1001-1005. https:\/\/doi.org\/10.1097\/AOG.0000000000004124","DOI":"10.1097\/AOG.0000000000004124"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Borchert K, Thibodeau C, Varin P, et al. Medication abortion and uterine aspiration for undesired pregnancy of unknown location: a retrospective cohort study. Contraception. 2023;122:109980. https:\/\/doi.org\/10.1016\/j.contraception.2023.109980","DOI":"10.1016\/j.contraception.2023.109980"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Brandell K, Jar-Allah T, Reynolds-Wright J, et al. Randomized trial of very early medication abortion. N Engl J Med. 2024;391(18):1685-1695. https:\/\/doi.org\/10.1056\/NEJMoa2401646","DOI":"10.1056\/NEJMoa2401646"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Goldberg AB, Fulcher IR, Fortin J, et al. Mifepristone and misoprostol for undesired pregnancy of unknown location. Obstet Gynecol. 2022;139(5):771-780. https:\/\/doi.org\/10.1097\/AOG.0000000000004756","DOI":"10.1097\/AOG.0000000000004756"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Goldstone P, Michelson J, Williamson E. Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac. Contraception. 2013;87(6):855-858. https:\/\/doi.org\/10.1016\/j.contraception.2012.10.013","DOI":"10.1016\/j.contraception.2012.10.013"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Heller R, Cameron S. Termination of pregnancy at very early gestation without visible yolk sac on ultrasound. J Fam Plann Reprod Health Care. 2015;41(2):90-95. https:\/\/doi.org\/10.1136\/jfprhc-2014-100924","DOI":"10.1136\/jfprhc-2014-100924"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Schaff EA, Fielding SL, Eisinger S, et al. Mifepristone and misoprostol for early abortion when no gestational sac is present. Contraception. 2001;63(5):251-254. https:\/\/doi.org\/10.1016\/S0010-7824(01)00200-1","DOI":"10.1016\/S0010-7824(01)00200-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Tai NQR, Reynolds-Wright JJ, Cameron S. Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy. BMJ Sex Reprod Health. 2023;49(2):97-104. https:\/\/doi.org\/10.1136\/bmjsrh-2022-201677","DOI":"10.1136\/bmjsrh-2022-201677"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fiala C, Safar P, Bygdeman M, et al. Verifying the effectiveness of medical abortion: ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol. 2003;109(2):190-195. https:\/\/doi.org\/10.1016\/S0301-2115(03)00012-5","DOI":"10.1016\/S0301-2115(03)00012-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Whitehouse KC, Stifani BM, Duffy JMN, et al. Standardizing abortion research outcomes (STAR): results from an international consensus development study. Contraception. 2021;104(5):484-491. https:\/\/doi.org\/10.1016\/j.contraception.2021.07.004","DOI":"10.1016\/j.contraception.2021.07.004"},{"key":"ref19","unstructured":"Kallfa E, Lauszus F, Ravn P. Control of the level of human chorionic gonadotropin in urine compared to the level of serum after medically provoked abortion is a safe alternative. Ugeskr L\u00e6ger. 2021;183:V03210262"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:52:36Z","timestamp":1786513956000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A11250983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.61409\/a11250983","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}